An experimental Alzheimer's drug shows promise targeting a different brain protein, new study shows
An experimental drug might help slow early Alzheimer's disease in a markedly different way than current treatments — by lowering the brain's production of a protein called tau
July 14, 2026
Missouri 19-year-old uses toy drive to help Missourians impacted by historic floods
Ontario asks for federal support for wildfire evacuations as smoke spreads
White House says it is closely monitoring food-borne illness outbreak
Citadel Securities invests $400 million in Crypto.com at $20 billion valuation
NTSB finds evidence of bird strike before fatal New York helicopter crash
Trump media firm plans to sell high speed access to Truth Social posts, possibly Trump's own